James Fadiman Ph.D. almost needs no introduction. An early pioneer of psychedelic research, a lifelong proponent of microdosing, and a prolific writer and educator, Jim played a pivotal role in reigniting the conversation around psychedelics in the US and beyond with the publication of his 2011 book, The Psychedelic Explorer’s Guide. In this wide-ranging podcast, Jim chats candidly with Paul Austin about everything from the early years of psychedelic research and the immeasurable benefits of microdosing, to the business of psychedelics, the power of citizen science, and the foundation of our personal identities.
Dr. Katherine Coder was on her way to a career on Wall Street when a psychedelic experience changed the course of her life. Now a counselor and coach, her mission is to help her clients reclaim their birthright and unfold their essential nature into the world. In this episode, Kat and Paul discuss the power of community, connecting to spirit, and pharmaceutical vs. shamanic approaches to healing through plant medicine.
Amanda Eilian has been actively investing in early stage consumer companies for the last decade, drawing on her experience as an institutional investor and entrepreneur. Her focus today is on companies that make the daily lives of consumers healthier, happier, and more meaningful. In this episode, Amanda and Paul discuss narrowing the wellness gap and investing in psychedelics for long-term solutions to mental illness.
A psychotherapist since 1989, Charley Wininger is also a licensed psychoanalyst and a mental health counselor who specializes in relationships and communication skills. His recent book, Listening To Ecstasy, tracks his personal experience with MDMA as a way to enhance his life and strengthen his marriage. In this podcast, he and Paul chat about the power of MDMA to solidify relationships, rediscover joy, and reconnect to ourselves and each other.
Dr. Craig Heacock, psychiatrist and ketamine treatment provider, offers a counterpoint to a previous guest’s view on mental illness and psychiatric medications. While his goal is always to have patients on as few medications as possible, Craig stresses the importance of correctly understanding the nuances of mental health and mental health treatments instead of painting with a broad brush. He and Paul also discuss the current state and near-future of psychedelic treatments for mental health, as well as the reception of psychedelics among the psychiatric community.